The role of the surgeon in treating patients with lung cancer. An updating article
Keywords:
Pulmonary surgical procedures, Thoracic surgical procedures, Pneumonectomy, Thoracic surgery, Lung neoplasmsAbstract
Lung cancer is a type of neoplasia with one of the highest incidences worldwide and is the largest cause of mortality due to cancer in the world today. It is classified according to its histological and biological characteristics, which will determine its treatment and prognosis. Non-small cell lung cancer accounts for 85% of the cases, and these are the cases that surgeons mostly deal with. Small cell lung cancer accounts for the remaining 15%. Surgery is the main method for treating early stage lung cancer, and lobectomy is the preferred procedure for treating primary lung cancer, while sublobar resection is an alternative for patients with poor reserve or with very small tumors. Surgeons need to be trained to use the resources and techniques available for lung resection, including less invasive approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS), and need to be familiar with new oncological approaches, including curative, adjuvant or palliative treatments for patients with lung cancer.
Downloads
References
International Agency for Research on Cancer. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Available from: https://www.iarc.who.int/featured-news/latest-global-cancer-data-cancer-burden-rises-to-18-1-million-new-cases-and-9-6-million-cancer-deaths-in-2018/ Accessed in 2021 (Feb 16).
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010. PMID: 25467588; doi: https://doi.org/10.1016/S0140-6736(14)62038-9 Erratum in: Lancet. 2015;385(9972):946.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409. PMID: 21714641; doi: https://doi.org/10.1056/NEJMoa1102873
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020;382(6):503-13. PMID: 31995683; https://doi.org/10.1056/NEJMoa1911793
Howlader N, Forjaz G, Mooradian MJ, et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020;383(7):640-9. PMID: 32786189; https://doi.org/10.1056/NEJMoa1916623
Araujo LH, Baldotto C, Castro Jr G de, Katz A, Ferreira CG, Mathias C, et al. Lung cancer in Brazil. J Bras Pneumol. 2018 Jan-Feb;44(1):55-64. PMID: 29538545; https://doi.org/10.1590/S1806-37562017000000135
Bouchardy C, Benhamou S, Schaffar R, et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer. 2011;117(6):1288-95. PMID: 21264820; https://doi.org/10.1002/cncr.25638
Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011 Dec;32(4):605-44. PMID: 22054876; https://doi.org/10.1016/j.ccm.2011.09.001
Instituto Nacional de Cancer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil/Instituto Nacional de Cancer José Alencar Gomes da Silva. Rio de Janeiro: INCA 2019. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf Accessed in 2021 (Feb 16).
Terra RM, Gouvêa FM, Araújo PHXN, Haddad R, Pêgo-Fernandes PM. Robotic-assisted thoracic surgery in Brazil, a review of the literature and our current experience. Journal of Visualized Surgery. 2019;5:15. Available from: https://jovs.amegroups.com/article/view/23915/pdf Accessed in 2021 (Feb 16).
Dietel M, Bubendorf L, Dingemans AM, et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group. Thorax. 2016;71(2):177-84. PMID: 26530085; https://doi.org/10.1136/thoraxjnl-2014-206677
Tamburini N, Maniscalco P, Mazzara S, et al. Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study. Eur J Cardiothorac Surg. 2018;53(6):1199-204. PMID: 29293943; https://doi.org/10.1093/ejcts/ezx464
Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S-e165S. PMID: 23649436; https://doi/org/10.1378/chest.12-2353
Detterbeck FC. The eighth edition TNM stage classification for lung cancer: What does it mean on main street? J Thorac Cardiovasc Surg. 2018;155(1):356-9. PMID: 29061464; https://doi.org/10.1016/j.jtcvs.2017.08.138
Hoy H, Lynch T, Beck M. Surgical Treatment of Lung Cancer. Crit Care Nurs Clin North Am. 2019;31(3):303-13. PMID: 31351552; https://doi.org/10.1016/j.cnc.2019.05.002
Abbas AE. Surgical Management of Lung Cancer: History, Evolution, and Modern Advances. Current Oncology Reports [Internet]. Curr Oncol Rep. 2018;20(12):98. PMID: 30421260; https://doi.org/10.1007/s11912-018-0741-7
Rami-Porta R, Wittekind C, Goldstraw P; International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: Proposed definition. Lung Cancer. 2005;49(1):25-33. PMID: 15949587; https://doi.org/10.1016/j.lungcan.2005.01.001
Ginsberg RJ, Rubinstein L. The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer: LCSG 821. Chest. 1994;106(6 Suppl):318S-319S. PMID: 7988253.
Bains MS. Surgical treatment of lung cancer. Chest. 1991;100(3):826-37. PMID: 1889280; https://doi.org/10.1378/chest.100.3.826
Schuchert MJ, Abbas G, Pennathur A, et al. Sublobar resection for early-stage lung cancer. Semin Thorac Cardiovasc Surg. 2010;22(1):22-31. PMID: 20813313; https://doi.org/10.1053/j.semtcvs.2010.04.004
Yano M, Yoshida J, Koike T. The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in Pathology. World J Surg. 2016;40(11):2688-97. PMID: 27365098; https://doi.org/10.1007/s00268-016-3596-9
Sakurai H, Asamura H. Sublobar resection for early-stage lung cancer. Transl Lung Cancer Res. 2014;3(3):164-72. PMID: 25806296; https://doi.org/10.3978/j.issn.2218-6751.2014.06.11
Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915-24. PMID: 30442588; https://doi.org/10.1016/S2213-2600(18)30411-9
Sawabata N. Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: Can it be reduced by considering cancer cells at the surgical margin? Gen Thorac Cardiovasc Surg. 2013;61(1):9-16. PMID: 23054616; https://doi.org/10.1007/s11748-012-0156-6
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015;10(9):1240-2. PMID: 26291007; https://doi.org/10.1097/JTO.0000000000000663
Eguchi T, Kameda K, Lu S, et al. Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis. J Thorac Oncol. 2019;14(1):87-98. PMID: 30244070; https://doi.org/10.1016/j.jtho.2018.09.005
Raman V, Jawitz OK, Voigt SL, et al. The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. Chest. 2021;159(1):390-400. PMID: 32652096; https://doi.org/10.1016/j.chest.2020.06.066
Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. “Early” peripheral lung cancer: Prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg. 2002;74(5):1635-9. PMID: 12440622; https://doi.org/10.1016/s0003-4975(02)03895-x
Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30(5):787-92. PMID: 16971134; https://doi.org/10.1016/j.ejcts.2006.08.008
Ray MA, Faris NR, Smeltzer MP, et al. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018;106(1):228-34. PMID: 29534956; https://doi.org/10.1016/j.athoracsur.2018.02.021
Varlotto JM, Recht A, Flickinger JC, et al. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer. 2009;115(5):1059-69. PMID: 19152440; https://doi.org/10.1002/cncr.24133
Hui R, Özgüroğlu M, Villegas A, et al. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Lancet Oncol. 2019;20(12):1670-80. PMID: 31601496; https://doi.org/10.1016/S1470-2045(19)30519-4
Pirker R. Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. Transl Lung Cancer Res. 2014;3(5):305-10. PMID: 25806316; https://doi.org/10.3978/j.issn.2218-6751.2014.09.13
Terra RM, Araujo PHXN, Lauricella LL, et al. Lobectomia pulmonar robótica para tratamento do câncer de pulmão e de metástases pulmonares: Implantação do programa e experiência inicial. J Bras Pneumol. 2016;42(3):185-90. https://doi.org/10.1590/S1806-37562015000000212
Terra RM, Kazantzis T, Pinto-Filho DR, et al. Ressecção pulmonar anatômica por videotoracoscopia: Experiência brasileira (VATS Brasil). Jornal Brasileiro de Pneumologia. 2016;42(3):215-21. Available from: https://www.jornaldepneumologia.com.br/details/2552/pt-BR/resseccao-pulmonar-anatomica-por-videotoracoscopia--experiencia-brasileira--vats-brasil- Accessed in 2021 (Feb 16).
Taioli E, Leea DS, Lesserc M, Flores R. Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis. Eur J Cardiothorac Surg. 2013;44(4):591-7. https://doi.org/10.1093/ejcts/ezt051
Falcoz PE, Puyraveau M, Thomas PA, et al. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg. 2016;49(2):602-9. PMID: 25913824; https://doi.org/10.1093/ejcts/ezv154
Cao C, Manganas C, Ang SC, Yan TD. A meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomy. Ann Cardiothorac Surg. 2012;1(1):16-23. PMID: 23977459; https://doi.org/10.3978/j.issn.2225-319X.2012.04.18
Paul S, Altorki NK, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010;139(2):366-78. PMID: 20106398; https://doi.org/10.1016/j.jtcvs.2009.08.026
Lim E, Batchelor T, Shackcloth M, et al. Study protocol for Video assisted thoracoscopic lobectomy versus conventional Open Lobectomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study). BMJ Open. 2019;9(10):e029507. PMID: 31615795; https://doi.org/10.1136/bmjopen-2019-029507
Tsukazan MTR, Terra RM, Vigo Á, et al. Video-assisted thoracoscopic surgery yields better outcomes than thoracotomy for anatomical lung resection in Brazil: A propensity score-matching analysis using the Brazilian Society of Thoracic Surgery database. Eur J Cardiothorac Surg. 2018;53(5):993-8. PMID: 29253098; https://doi.org/10.1093/ejcts/ezx442
Tsukazan MTR, Terra RM. VATS versus open thoracic surgery in Brazil—where are we standing? J Vis Surg. 2018;4:249. Available from: https://jovs.amegroups.com/article/view/23011/html Accessed in 2021 (Feb 16).
Younes RN, Deutsch F, Badra C, et al. Nonsmall cell lung cancer: evaluation of 737 consecutive patients in a single institution. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(3):119-27. PMID: 15286831; https://doi.org/10.1590/s0041-87812004000300005
Novaes FT, Cataneo DC, Ruiz Junior RL, et al. Lung cancer: histology, staging, treatment and survival. J Bras Pneumol. 2008;34(8):595-600. PMID: 18797744; https://doi.org/10.1590/s1806-37132008000800009
Araujo LHL, Baldotto CS, Zukin M, et al. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de células não pequenas assistidos na saúde suplementar. Ver Bras Epidemiol. 2014;17(4):1001-14. https://doi.org/10.1590/1809-4503201400040017
Melfi FM, Menconi GF, Mariani AM, Angeletti CA. Early experience with robotic technology for thoracoscopic surgery. Eur J Cardiothorac Surg. 2002;21(5):864-8. PMID: 12062276; https://doi.org/10.1016/s1010-7940(02)00102-1
Kent M, Wang T, Whyte R, et al. Open, video-assisted thoracic surgery, and robotic lobectomy: Review of a national database. Ann Thorac Surg. 2014;97(1):236-42; discussion 242-4. PMID: 24090577; https://doi.org/10.1016/j.athoracsur.2013.07.117
Chen Y, Zhang J, Chen Q, et al. Three-dimensional printing technology for localised thoracoscopic segmental resection for lung cancer: a quasi-randomised clinical trial. World J Surg Oncol. 2020;18(1):223. PMID: 32838798; https://doi.org/10.1186/s12957-020-01998-2
Wu YL, Tsuboi M, He J, et al. Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer. N Engl J Med. 2020;383(18):1711-23. PMID: 32955177; https://doi.org/10.1056/NEJMoa2027071
Gomez DR, Tang C, Zhang J, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019;37(18):1558-65. PMID: 31067138; https://doi.org/10.1200/JCO.19.00201
